Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Wibeke J van Leeuwen"'
Autor:
Jaan-Olle Andressoo, Judith Jans, Jan de Wit, Frederic Coin, Deborah Hoogstraten, Marieke van de Ven, Wendy Toussaint, Jan Huijmans, H Bing Thio, Wibeke J van Leeuwen, Jan de Boer, Jean-Marc Egly, Jan H J Hoeijmakers, Gijsbertus T J van der Horst, James R Mitchell
Publikováno v:
PLoS Biology, Vol 4, Iss 10, p e322 (2006)
Although compound heterozygosity, or the presence of two different mutant alleles of the same gene, is common in human recessive disease, its potential to impact disease outcome has not been well documented. This is most likely because of the inheren
Externí odkaz:
https://doaj.org/article/83407a93728844b9ac00439c4e15c8e6
Autor:
Deborah Hoogstraten, Wibeke J. Van Leeuwen, J. G. M. Huijmans, Frédéric Coin, Jean-Marc Egly, Marieke van de Ven, Judith Jans, Wendy Toussaint, James R. Mitchell, Jaan-Olle Andressoo, H. Bing Thio, Gijsbertus T. J. van der Horst, Jan H.J. Hoeijmakers, Jan de Wit, Jan de Boer
Publikováno v:
PLoS Biology
PLoS Biology (print), 4(10), 1821-1830. Public Library of Science
PLoS Biology, 2006, 4 (10), pp.e322. ⟨10.1371/journal.pbio.0040322⟩
PLoS Biology, Public Library of Science, 2006, 4 (10), pp.e322. ⟨10.1371/journal.pbio.0040322⟩
PLoS Biology, Vol 4, Iss 10, p e347 (2006)
PLoS Biology, Vol 4, Iss 10, p e322 (2006)
PLoS Biology (print), 4(10), 1821-1830. Public Library of Science
PLoS Biology, 2006, 4 (10), pp.e322. ⟨10.1371/journal.pbio.0040322⟩
PLoS Biology, Public Library of Science, 2006, 4 (10), pp.e322. ⟨10.1371/journal.pbio.0040322⟩
PLoS Biology, Vol 4, Iss 10, p e347 (2006)
PLoS Biology, Vol 4, Iss 10, p e322 (2006)
Although compound heterozygosity, or the presence of two different mutant alleles of the same gene, is common in human recessive disease, its potential to impact disease outcome has not been well documented. This is most likely because of the inheren
Autor:
Gijsbertus T. J. van der Horst, Esther Appeldoorn, Astrid S. Lalai, George A. Garinis, Arjan F. Theil, Peter Meinecke, Laura J. Niedernhofer, Wibeke J. Van Leeuwen, Roos Oostendorp, Jan Vijg, Wim Vermeulen, Hanny Odijk, Wim J. Kleijer, Andria Rasile Robinson, Jan H.J. Hoeijmakers, Anja Raams, Nicolaas G. J. Jaspers, Anwaar Ahmad
Publikováno v:
Nature, 444, 1038-1043. Nature Publishing Group
XPF-ERCC1 endonuclease is required for repair of helix-distorting DNA lesions and cytotoxic DNA interstrand crosslinks. Mild mutations in XPF cause the cancer-prone syndrome xeroderma pigmentosum. A patient presented with a severe XPF mutation leadin
Autor:
Willy Sikma, Jonas Ranstam, Eric H Garling, Annechien Beumer, Bart A Swierstra, Edward R. Valstar, Ruud Niesing, Wibeke J van Leeuwen
Publikováno v:
Acta orthopaedica Scandinavica, 74(2), 201-205. Taylor and Francis Ltd.
Acta Orthopaedica Scandinavica, 74(2), 201-205. Informa Healthcare
Acta Orthopaedica Scandinavica, 74(2), 201-205. Informa Healthcare
We compared the value of 7.5 Nm external rotation stress in diagnosing tibiofibular syndesmotic injuries of the ankle on lateral radiographs with radiostereometric analysis (RSA) in 10 cadaveric legs. After sectioning 2 ligaments, RSA showed an incre
Autor:
Harry van Steeg, Jan de Wit, Gijsbertus T. J. van der Horst, Morteza Meradji, Jaan-Olle Andressoo, Wibeke J. Van Leeuwen, Geert Weeda, Axel P. N. Themmen, Rudolph B. Beems, J. G. M. Huijmans, Jan H.J. Hoeijmakers, Jan de Boer
Publikováno v:
Science, 296, 1276-1279. American Association for the Advancement of Science
One of the factors postulated to drive the aging process is the accumulation of DNA damage. Here, we provide strong support for this hypothesis by describing studies of mice with a mutation in XPD , a gene encoding a DNA helicase that functions in bo
Autor:
Rick R. van Rijn, Theo Stijnen, Stenvert L. S. Drop, Wibeke J. Van Leeuwen, Arne van Teunenbroek, Anjalie Asarfi, Sabine M.P.F. de Muinck Keizer-Schrama, Theo C. J. Sas
Publikováno v:
Clinical Endocrinology. 52:531-536
OBJECTIVE The aim of this study was to assess the volumetric bone mineral density (BMD) in girls with Turner's syndrome (TS) before and during growth hormone (GH) treatment in combination with low dose oestrogens as well as three years after disconti